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The interaction of the incoming beam radiation with the patient body in hadrontherapy 
treatments produces secondary charged and neutral particles, whose detection can be 
used for monitoring purposes and to perform an on-line check of beam particle range. In 
the context of ion-therapy with active scanning, charged particles are potentially attrac-
tive since they can be easily tracked with a high efficiency, in presence of a relatively low 
background contamination. In order to verify the possibility of exploiting this approach 
for in-beam monitoring in ion-therapy, and to guide the design of specific detectors, both 
simulations and experimental tests are being performed with ion beams impinging on 
simple homogeneous tissue-like targets (PMMA). From these studies, a resolution of the 
order of few millimeters on the single track has been proven to be sufficient to exploit 
charged particle tracking for monitoring purposes, preserving the precision achievable 
on longitudinal shape. The results obtained so far show that the measurement of charged 
particles can be successfully implemented in a technology capable of monitoring both 
the dose profile and the position of the Bragg peak inside the target and finally lead to 
the design of a novel profile detector. Crucial aspects to be considered are the detector 
positioning, to be optimized in order to maximize the available statistics, and the capa-
bility of accounting for the multiple scattering interactions undergone by the charged 
fragments along their exit path from the patient body. The experimental results collected 
up to now are also valuable for the validation of Monte Carlo simulation software tools 
and their implementation in Treatment Planning Software packages.
Keywords: hadrontherapy, real time monitoring, particle detection
1. INTRODUCTION
The use of particle therapy (PT) is becoming more and more effective for the treatment of solid 
cancer. The most common beams used nowadays in PT are protons, while the use of carbon ions, 
available worldwide only in a limited number of treatment centers, is now becoming more and 
more attractive.
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The implementation of PT treatments that use 4He beams, 
considered so far for the treatment of uveal melanoma (1, 2) and 
of patients with meningioma of the skull base or spine (3) is now 
being considered also for pencil beam treatments (4). The use 
of 16O beams (5), another option, is also envisaged in the near 
future (6).
Light ion beams have a peculiar profile of released dose in tis-
sues: this makes these beams very effective in the selective treat-
ment of tumors, sparing the adjacent healthy tissues, compared 
with the standard X-ray-based treatment (7). A consequence of 
this higher spatial selectivity of PT is also stringent requirements 
on the accuracy that has to be achieved in the delivered dose 
monitoring.
Several factors affect the uncertainty on the position of the 
dose release in PT treatments. The calibration of the computed 
tomography (CT) images, or morphologic changes that can 
occur between the CT and the several irradiation sessions of a 
PT treatment, operated in different days, are among these pos-
sible sources of uncertainty. The correct dose release can also be 
affected by patient mis-positioning and organ motion during the 
treatment. All these contributions can sum up to a total uncer-
tainty of the order of few millimeters on the actual voxel under 
treatment (8).
The treatment planning system (TPS) carefully manages the 
region around the tumor and the organs at risk, using a safety 
factor on the deliverable dose accounting for the uncertainty 
on its distribution. In order to protect the patient from the risks 
due to possible dose release misplacement, the number and the 
geometry of the treatment beam fields are properly designed.
A real-time monitoring procedure can, therefore, increase 
the quality assurance and the efficacy of a PT treatment (9). The 
main goal of on-line, “in-treatment,” monitoring devices is the 
measurement of the dose release longitudinal shape, and in par-
ticular the determination of the actual Bragg peak (BP) position 
for each beam energy and target voxel. The physical processes of 
ion beam interaction with the tissues drive the energy release to 
proceed through electromagnetic interactions with the patient, 
while the emission of radiation escaping the patient, allowing 
for an imaging of its source, is due to strong interactions. These 
processes are the basis of the development of new approaches for 
the determination of the BP position.
There are three nuclear processes well suited for monitoring 
applications: production of β+ emitters nuclei, excitation of 
nuclei, and charged particle production in inelastic interactions. 
Nuclear β+ decays produce positrons that annihilate with the 
electrons surrounding the emission position and yield almost 
back-to-back 511  keV photon pairs. Photon detection can be 
exploited to measure the β+ production position, and correlate 
it with the Bragg peak position (10–14). Since the organic tissue 
is mostly constituted of carbon, hydrogen, and oxygen, the β+ 
emitting isotopes that are most likely to be produced are 10C, 11C, 
15O, and 13N.
The beam interaction with the patient body, along the path 
toward the target voxel, can also excite nuclei and produce de-
excitations photons emitted in a very short (<1 ns) decay time 
interval (prompt photons). The energy range of these photons 
extends up to about 10 MeV (15–18).
The target nucleus fragmentation, to which the projectile 
fragmentation has to be added in the case of PT performed 
with ions heavier than protons, can result in the production of 
charged fragments of smaller mass that could be exploited for 
monitoring purposes. Such fragmentation is a high cross-section 
strong process that it is not trivial to describe and quantify in 
the energy regime of interest, where the interaction projectiles 
have an energy ranging between 20 and 200 MeV/u and nuclear 
interactions are particularly difficult to model.
The velocity of fragmentation products is close to, or even 
larger than that of primary ions, while the latter experience a 
higher stopping power. For this reason, the fragments range is 
longer with respect to that of beam particles: this reflects into 
a characteristic dose tail behind the BP. This effect is particu-
larly relevant for the treatments; therefore, it has been studied 
with dedicated nuclear cross-section experiments (19, 20) and 
with measurements of carbon ion collisions with water targets 
(21–24). By these experiments, fragmentation products proven 
to be peaked in the forward region and mostly contained within a 
cone of few degrees with respect to the beam axis. Protons, which 
represent the largest contribution, showed instead tails at large 
emission angles.
Several measurements have been performed during the last 
decade, to evaluate the dose contribution for healthy tissues, 
due to the production of beam fragments. More recent studies 
have been focused on the possibility of exploiting the secondary 
particle production (and in particular the highly penetrating 
proton component) for monitoring purposes, as it can be used to 
estimate the position of the dose profile distal edge.
A first proposal was advanced in Ref. (25) that introduced 
the method of “interaction vertex imaging” (IVI); this method 
aims at reconstructing the nuclear emission vertices distribu-
tion and correlates it with the BP position, by the detection of 
secondary protons. In measurements performed at small angle 
(26, 27), using solid state tracking devices at 30° with respect 
to the beam direction, the distal edge of the beam has been 
estimated with an accuracy of 1.3 mm. In addition, variations 
of the beam width (transverse dimension) have been measured 
with a precision of 0.9 mm.
On the basis of simple geometrical considerations, the 
production at large angles with respect to the incoming beam 
direction appears to be the most interesting for monitoring 
applications. The quality of the single charged particle trajectory 
reconstruction at large angles compensates for the expected 
reduced statistics.
It is naturally expected that the charged particle yield at large 
angle remains relevant in the case of beams of particles heavier 
than protons. Therefore, the use of charged particle detection 
for the on-line monitoring of PT treatments can be especially 
appealing in carbon therapy. The effective implementation of 
this technique requires the investigation of several different 
aspects. The spatial distribution of charged particles emitted at 
large angle by a tissue-equivalent target irradiated by a therapeu-
tic beam has to be measured accurately in order to exploit the 
correlation with the longitudinal dose profile and, finally, with 
the BP position. These measurements have to be performed as a 
function of different projectile types and energies, characterizing 
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the yield of the different produced fragments and their angular 
distribution. Furthermore, in order to make an effective use of 
this approach in clinical practice, it is necessary to correlate each 
detected track with the position and direction of the primary 
beam. This also allows to take into account energy loss and scat-
tering in the patient’s materials. Therefore, this methodology for 
on-line monitoring can be effectively applied to ion therapy with 
active beam scanning (28).
The design and implementation of a tracking device suitable 
for clinical applications will also require an accurate study 
and optimization of the detector size and positioning in order 
to maximize the achievable track yield and detection resolu-
tion and match the clinical requirements on the dose release 
monitoring.
In section 2, we will review the main available experimental 
results regarding the yield of charged particles produced by thera-
peutic beams interaction with different targets. In section 3, the 
methods to correlate the spatial distribution of measured second-
ary particles with the BP position will be presented, introducing 
also some general considerations about the actual feasibility of 
charged particle monitoring in ion beam therapy.
2. CHARGED PARTICLES PRODUCTION 
BY THERAPEUTIC BEAMS
The research and development process of novel techniques for 
on-line monitoring applications to PT treatments relies heavily 
on a detailed experimental knowledge of the secondary radia-
tions emitted by beam interaction with the patient body.
Improving the accuracy on the measurement of the flux 
of secondary particles and their angular and kinetic energy 
spectra has been the main goal of several experiments recently 
performed in the research centers of Laboratori Nazionali 
del Sud (LNS, Catania), Helmholtzzentrum Gesellschaft für 
Schwerionenforschung (GSI, Darmstadt), Heidelberg Ion-Beam 
Therapy center (HIT, Heidelberg), and Grand Accélérateur 
National d’Ions Lourds (GANIL, Caen) with ion beams of differ-
ent types and energies.
Helium, carbon, and oxygen ion beam interactions with 
water or polymethyl methacrylate (PMMA) targets of different 
shapes were studied, in the beam energy range relevant for had-
rontherapy monitoring applications, by means of high efficiency 
charged particle tracking detectors.
Charged fragments, subject of this review, have been studied 
in two different angular ranges: particles detected at an angle 
θ with respect to the beam incoming direction between 0° and 
45° (26, 27) and particles detected at large θ (60°, 90°, and 120°) 
angles (29, 30).
The θ spectrum of produced particles is of key importance 
when designing on-line monitoring devices to be integrated 
in hadrontherapy treatment rooms. The quest for the highest 
statistics data sample is hardened by the mechanical restrictions 
imposed by the patient positioning and related safety devices, and 
has also to account for beam induced background and backtrack-
ing issues for configurations at angles close to the beam incoming 
direction.
Although the secondary production at large angle was thought 
for a long time to be negligible, the experimental results have 
actually unveiled that the light charged fragments production, 
mainly protons and hydrogen isotopes, occurs even at very large θ 
angles with an integrated yield compatible with the requirements 
set by on-line monitoring applications.
The measurements performed with a small PMMA target 
(4 cm thickness) at LNS using a carbon beam with 80 MeV/u 
energy, also confirmed that a significant production of charged 
fragments occurs in BP proximity (29). This experimental result 
suggests that monitoring by means of charged fragments detec-
tion could be exploited also superficial tumor treatments.
Hereafter, we present the experimental setup used for the dif-
ferent measurements and the yield of charged particles produced 
at different angles.
2.1. Small Angle Production
A first set of measurements was performed at HIT (26), using 
carbon ions, of kinetic energies relevant for PT applications, 
impinging on a cylindrical PMMA phantom with size compa-
rable to the human head (diameter: 160 mm, height: 90 mm). 
Aim of the test was to characterize the beams available in the HIT 
facility, looking at the secondary charged fragments produced in 
the interaction with the PMMA target.
The beams available in HIT have full width at half maxi-
mum (FWHM) values that are energy-dependent and range 
typically from 4 to 20 mm. The available energies, in the range 
of 48–221 MeV for protons and 89–430 MeV/u for carbon ions, 
correspond to beam ranges in water between 2 and 30 cm.
The directions of secondary charged particles emitted from 
the PMMA phantom were measured using two parallel 300-μm 
thick silicon pixel layers at a distance of 3.6 mm (Timepix detec-
tor). The Timepix (31) detector was placed at θ = 30° at a 10-cm 
distance from the PMMA center. The choice of the θ angle was 
driven by the needed robustness of the back-projection method 
for the data analysis on the one hand, and by the secondary ion 
yield, i.e., the multiplicity of secondary ions per primary ion, 
which decreases with increasing angle from the beam axis, on 
the other.
Different energy, width, and position configurations of the 
carbon beam were studied. The nominal beam intensity was set 
to 2 × 107 ions/s and for each investigated beam parameter setting 
and about 2 × 109 primary carbon ions were irradiated on the 
phantom when collecting the various data samples. The obtained 
secondary charged particle directions were analyzed using the 
back-projection method from Ref. (32).
In all the tested configurations, a non-negligible production of 
charged particles was observed with a production spectrum that 
was correlated to the dose release in the phantom, as shown in 
Figure 1 for a carbon ion beam of 250.08 MeV/u kinetic energy 
and FWHM of 4.3 mm.
As the principal aim of the test was to characterize the beam 
parameters with the tracking detector, no measurement of the 
charged fragments flux was performed. However, taking into 
account that the size of the sensitive area of the used detector 
(~2 cm2) allows to cover only a small fraction (~0.15%) of the 
FIGURE 1 | Distribution of the track back-projections for 5 × 104 measured secondary charged particles produced by the interaction of a carbon 
beam with a PMMA phantom at the HIT facility (26). The dimensions of the cylindrical PMMA phantom are illustrated by the black rectangle (view from the 
side). The origin of the coordinate system is aligned with the center of the phantom that was placed in the isocentre. The carbon ion beam was directed along the 
Z-axis. The depth dose distribution measured in water and scaled to the phantom water equivalent path length (WEPL) is shown by the red curve. Due to 
experimental limitations, the depth-dose distribution could be measured only for water depths greater than 20 mm. Initial carbon ion beam parameters: 
E = 250.08 MeV/u, FWHM = 4.3 mm. © Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. All rights reserved.
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forward hemisphere around a patient, and that by decreasing 
the detector dead time and using a ring of detectors around the 
patient will greatly enhance the particles statistics, the authors 
concluded, on the basis of the measured yields, that the monitor-
ing of single beam spots at the distal edge of typical brain tumor 
treatments with charged particles is a realistic opportunity.
Other tests were performed at small angles using PMMA 
and water targets: a 95 MeV/u 12C beam was used at GANIL 
(21) to study the fragments production from PMMA targets 
of various thicknesses at small angles; a 200 MeV/u 12C beam 
was used at GSI (22) to study the production of light fragments 
from the beam interaction with a 128-mm-thick water target at 
θ < 30°; a 310 MeV/u 12C ion beam irradiating a 21-cm-thick 
water target was used to study the light fragments production 
at 30° and 45° (27).
While the GANIL studies implemented ΔE-E telescopes at 
different angles, using thin silicon layers and a final stage with CsI 
and BGO ~7.5-cm-long scintillators placed ~20 cm away from 
the target, the GSI experiment used ΔE-E telescope built with a 
NE102 scintillator paddle followed by a BaF2 crystal placed 3 m 
away from the target. In the GANIL setup, the charged fragment 
identification was performed using the ΔE vs. E distributions, 
while in the GSI experiment performed using the 200 MeV/u 
carbon ion beam the additional information coming from the 
fragments time of flight computed using the BaF2 detector signals 
was used.
In the study performed with the 310 MeV/u energy carbon 
ion beam, a single telescope was alternatively placed at 30° and 
45° with respect to the beam and in the forward direction, at 
a distance of 2.2 m from the target center. This telescope was 
composed by a thin plastic scintillator followed by a NaI(Tl) 
scintillator cylinder 5 cm in diameter and 5 cm in length. Thin 
scintillators were set upstream from the target to allow Time 
of Flight (ToF) measurements, triggered by incident ions, as it 
was done for the study performed at 200 MeV/u. The ToF of 
the detected particle, together with the energy deposited in the 
telescope detector, allowed to identify protons, deuterons, and 
tritons. Figure 2 shows the results obtained for the 310 MeV/u 
beam data sample (right) compared to Monte Carlo simulation 
(left) performed with the Geant v.4 9.2 toolkit (33).
High-energy particles, with ToF lower than a given threshold, 
escape the scintillator depositing only a fraction of their energy 
in it. This determines the triangular shape of the distributions for 
each particle type. The maximum equivalent energy deposited 
by protons in the 5 cm long NaI scintillator (upper point of the 
triangular shape distribution), on the vertical axis, was set to the 
corresponding energy deposition calculated by SRIM (34).
Figure  3 shows the measured and simulated values of the 
detected proton yields as a function of the detection angle for 
the three beam energies (95, 200, and 310 MeV/u). The observed 
yield decrease is consistent between data and MC, as a function of 
the θ angle. The yield discrepancies between open symbols (exp. 
data) and filled symbols (sim.) are at most at the 40% level. The 
observed yields in all the angular configurations are compatible 
with the requirements of on-line monitoring applications, as 
discussed in Section 3.
2.2. Large Angle Production
The production of charged secondary particles from the irradia-
tion of a PMMA target has been studied at large θ angles (≥60°) 
for fully stripped carbon ion beams at the LNS, GSI, and HIT 
facilities with energies ranging from 80 to 220  MeV/u. The 
experimental setup, which had only small variations in the dif-
ferent laboratories where the data acquisition was performed, 
is presented in a schematic view in Figure 4 for the experiment 
performed in GSI using a carbon beam of 220 MeV/u energy 
impinging on a PMMA target.
The tracking detectors and the details of the analysis per-
formed on the reconstructed track sample are common to all the 
experiments.
An array of 4 LYSO crystals, each measuring 1.5 cm × 
1.5 cm × 12 cm, was placed at 60°, 90°, and 120° with respect to 
the beam line, at ~70 cm from the PMMA center. The scintilla-
tion light of the crystals was detected with a PMT triggered in 
FIGURE 3 | From Ref. (27): experimental (open symbols) and 
simulated (filled symbols) proton emission yields as a function of 
emission angle and carbon ion energy (and target thickness): 
310 MeV/u 12C, 210 mm water target (GSI experiment), 200 MeV/u 12C, 
128 mm water target (22), and 95 MeV/u 12C, 25 mm PMMA target (21). 
Simulations performed with the QMD (circles) and BC (triangles) models are 
shown. © Institute of Physics and Engineering in Medicine. Reproduced by 
permission of IOP Publishing. All rights reserved.
FIGURE 2 | From Ref. (27): energy vs. time of flight (expressed in nanoseconds) distributions obtained for 310 MeV/u carbon ions incident on a 
21-cm-thick water target with the telescope located at 30° with respect to the beam direction at 2.2 m from the target center. Left: simulation with Geant 
v.4 9.2 toolkit, right: measurements (GSI experiment). p, d, and t refer to protons, deuterons, and tritons in the simulated distributions (the background events are mainly 
due to fragmentation reactions in the scintillator). © Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. All rights reserved.
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coincidence, within 80 ns, with the Start Counter system sketched 
in Figure 4. Details on the energy and time calibration of the 
LYSO crystals can be found in Ref. (35).
A 21-cm-long drift chamber (20) was placed at ~50 cm from 
the PMMA center, along the line of flight connecting the PMMA 
to the LYSO crystals. The drift chamber provided a 2-dimensional 
track reconstruction by alternated horizontal (x-z plane V-view) 
and vertical (y-z plane U-view) layers of wires. Twelve layers, six 
on each view, provided high tracking efficiency, tracking redun-
dancy, and excellent spatial resolution, which turned out to be 
≤200 μm with a single cell efficiency of ≃ 96%.
The experimental setup has been simulated by means of 
the FLUKA Monte Carlo software (36, 37) taking into account 
the trigger logic, the experimental energy thresholds and the 
quenching effect in the scintillator (38). MC results have been 
used to evaluate the setup efficiencies, geometrical accept-
ances, and to guide the development and tuning of the Particle 
IDentification.
The main difference with respect to what reported in Figure 4 
for the 80 MeV/u nucleon energy measurement performed at LNS 
is the absence of Start Counter 2, since only one start counter was 
used, and the absence of the Veto detector. Furthermore, the LNS 
experiment was performed only detecting charged fragments at 
90° with respect to the beam incoming direction.
The HIT experimental setup, used to study helium, carbon, 
and oxygen beams was using only one start counter, as well, but 
implemented a different Veto detector: a Long Thin Scintillator 
(LTS) was used and placed just along the PMMA, between the 
target and the DCH detector, in order to compute the Time of 
Flight of the charged fragments. The angular production configu-
rations that were tested were, respectively, θ = 60° and 90°.
In the LNS experiment, the interactions of an 80  MeV/u 
fully stripped 12C ion beam with a 4 cm × 4 cm × 4 cm PMMA 
target were studied (29). At GSI a thicker, 20 cm × 5 cm × 5 cm, 
PMMA target was irradiated with a 220 MeV/u fully stripped 12C 
beam (30). During the GSI data taking the PMMA phantom was 
positioned on a movable table, connected to a micrometric screw, 
capable of shifting the phantom position along the beam (x) axis 
of about few millimeters.
The beam rate in all cases, ranged from hundreds of kilo Hertz 
to few Mega Hertz and was monitored with a 1.1-mm-thick 
FIGURE 4 | From Ref. (30): top schematic view of the experimental setup for the 90° configuration used for the data acquisition performed in the GSI 
laboratory using a fully stripped carbon ion beam of 220 MeV/u. The small differences presented in the LNS and GSI setup are described in detail in the text. 
© Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. All rights reserved.
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scintillator (Start Counter) placed on the beam line between the 
beam exit window and the PMMA entrance side.
Charged particles were identified starting from the tracks 
reconstructed in the DC using at least eight fired cells (hits), 
since tracks traversing the full detector are expected to have 
twelve hits associated. To identify the tracks, the distribution of 
the deposited energy in the LYSO detector (ELYSO) as a function 
of Time of Flight (ToF) was exploited. As an example, Figure 5 
shows the measured distribution for the data collected at LNS. In 
the data sample (left panel) for ToF values around zero, the area 
delimited by the first dashed line is populated by a fast low-energy 
component, due to electrons produced, in the PMMA material, 
by Compton scattering of the de-excitation photons induced by 
beam interactions.
The central most populated band, delimited by the two dashed 
lines, is constituted by protons whose detected energy spans 
within a very wide range. These protons also caused the satura-
tion of the LYSO crystals QDC for ELYSO > 24 MeV, clearly visible. 
Similar populations in the (ToF, ELYSO) plane with an additional 
component of deuterons, above the second dashed line, are 
shown by the FLUKA simulation (right panel). This component 
is not clearly visible in data.
The data signature, with the bands relative to the different 
hydrogen isotopes, is common to all the experiments performed 
in the LNS, GSI, and HIT facilities, with a relative population of 
the different bands that depends on the beam type, beam energy, 
and settings (RMS), the PMMA thickness traversed by the frag-
ments toward the exit window, as well as the possible different 
response of the LYSO crystals. The saturation that can be seen in 
the data distribution at energies ELYSO larger than 23 MeV is due 
to the limited range of the QDC used during the data acquisition.
The only band visible in the (ToF, ELYSO) plane for the data 
collected at LNS (shown in Figure 5) has been defined using the 
data and MC distributions in order to identify and select protons 
in the data sample and measure their yield.
Similar distributions in the (ToF, ELYSO) plane have been 
observed for the GSI 220 MeV/u data both at 90° and 60°. The 
velocity (β) spectrum of secondary charged particles represents 
an important information for monitoring purposes, since, in 
order to emerge from the patient’s body and to be detected, they 
have to cross several centimeters of tissue. The β values distribu-
tions were obtained in two different ways in the LNS and GSI, 
HIT data analyses. While for the HIT test, the measurement 
of the ToF of the charged fragments was performed directly 
using the signal from a scintillator close to the exit path of the 
fragment inside the PMMA target; in the LNS and GSI setup, 
no dedicated detector was available and a dedicated unfolding 
had to be performed to take into account the travel time of the 
incoming ion inside the PMMA and the occurrence of secondary 
fragment production.
Figure  6 shows the distributions of β = vc  and the corre-
sponding detected kinetic energy Ekin for the identified protons, 
obtained using the ToF measurement together with the distance 
between LYSO crystals and PMMA for the data collected at LNS. 
This detected kinetic energy can be related to the proton kinetic 
energy at emission time, Ekin
Prod, considering the energy loss in the 
PMMA and the quenching effect of the scintillating light for low 
energy protons.
FIGURE 6 | From Ref. (29): distribution of β = vc  (left) and kinetic energy (right) of charged secondary particles identified as protons in the LNS data 
sample. © Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. All rights reserved.
FIGURE 5 | From Ref. (29): distribution of the detected energy in the LYSO crystals as a function of the Time of Flight for the data sample collected 
at the LNS facility using a carbon ion beam at 80 MeV/u. The distribution observed in the data (left) and FLUKA Simulation (right) samples are shown. 
© Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. All rights reserved.
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In the analysis of the particle ToF for the GSI data, the finite 
size of the beam spot, multiple scattering of charged particles 
traversing the PMMA target, different energy losses, and slow-
ing down of the various isotopes that passed through the target 
were taken into account. The sample is dominated by the proton 
contribution both in 90° and 60° samples.
The β distributions (βrec) of the dominant protons contribution 
are shown in Figure 7 for the setup configuration at 90° (squares) 
and 60° (circles), respectively. For each angular configuration, all 
spectra were normalized to the relative number of isotope species 
detected by the LYSO crystal. In order to use the secondary protons 
for monitoring purposes, the effect of crossing some centimeters 
of patient’s tissue has to be taken into account. Therefore, protons 
with detected kinetic energies greater than 50–60 MeV are the 
most interesting for the above-mentioned application.
Using the data collected at LNS, the flux of the secondary 
protons emitted from the beam interaction with the PMMA has 
been measured at 90° with respect to the beam direction and in 
the geometrical acceptance of the triggering LYSO crystals, since 
this configuration maximizes the sensitivity to the Bragg peak 
position. To determine the rate of emitted charged secondary 
particles that reached the LYSO crystals, the number of carbon 
FIGURE 7 | From Ref. (30): measured emission velocity (βrec) 
distributions for protons in the data sample collected at the GSI 
facility using a 220 MeV/u carbon ion beam. The error bars show the 
total (statistical plus systematic) uncertainty. © Institute of Physics and 
Engineering in Medicine. Reproduced by permission of IOP Publishing. All 
rights reserved.
FIGURE 8 | Emission profile of the charged fragments in the case of 
the 12C beam at different energies at θ = 90° with respect to the 
primary beam direction.
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ions impinging on the PMMA target has been calculated by 
counting the number of signals in the Start Counter taking into 
account the Start Counter efficiency, the discrimination time and 
the acquisition dead time.
The minimum required energy to detect a proton in the 
LYSO crystals was evaluated using the FLUKA simulation to be 
Ekin
Prod  MeV= . ± .7 0 0 5 . FLUKA has also been used to compute the 
emission energy (EkinProd  MeV)= ±83 5  of a proton with an average 
detected kinetic energy Ekin = 60 MeV. The uncertainty that affects 
the result is mainly due to the finite size of both the beam spot ' 
(1 cm) and profile.
The production fluxes of light charged fragments at 90° with the 
80 MeV/u LNS carbon beam, obtained requiring a kinetic energy 
at production greater than 7 or 83 MeV are, hence, respectively 
(7. 1 ± 0.14stat ± 0.32sys) × 10−5sr−1 and (2.14 ± 0.06stat ± 0.10sys) × 
10−5sr−1 with the systematic contribution mainly due to identifica-
tion of protons and to the uncertainty on the production kinetic 
energy related to the beam’s transversal profile uncertainty. A very 
good stability of the result is observed with respect to the rate of 
the carbon ions impinging on the PMMA.
In a similar way, the results for the Z = 1 overall charged parti-
cles fluxes have been measured at GSI. The results obtained using 
a 220 MeV/u carbon ion beam, for the 60° and 90° experimental 
configurations are the following:
 
dN
dN d
sr
C
stat sysΩ
( ) ( )θ = = . ± . ± . × − −60 12 59 0 08 0 76 10 3 1D
 
 
dN
dN d
sr
C
stat sysΩ
( ) ( )θ = = . ± . ± . × − −90 2 74 0 02 0 16 10 3 1D
 
where the leading contributions to the systematic uncertainty is 
the evaluation of the dead time in data acquisition. The results 
are compatible with the extrapolations made from the yields 
measured at smaller angles and measured with different ion beam 
energies and target media.
The data taken with 12C beam at HIT confirmed the GSI 
measurements and non-negligible production of protons at large 
angles was also observed for other ion species. Figure 8 shows 
the longitudinal emission profiles of protons detected at θ = 90°, 
for carbon beams at four different energies (120, 160, 180, and 
220 MeV/u). As in Ref. (30), the emission shape could be cor-
related to the beam entrance window and the BP position. While 
the fluxes calculation is still being finalized, the production of 
charged secondary fragments at large angle is found to be consist-
ent with what already measured in different experimental setups 
and centers.
The HIT experimental setup was also used to measure the 
secondary particles production that occurs in the PMMA targets 
by the interactions of 4He and 16O beams at therapeutical ener-
gies. When studying these ion beam particles, the thickness of 
the PMMA target was changed as a function of the ion type and 
energy, in order to keep the BP at about 1 cm before the end of the 
target. This configuration was used in order to reduce to a mini-
mum the systematic uncertainty related to the forward interaction 
of the heavy fragments with the PMMA target after the BP, for the 
forward production studies performed with BGO detectors.
The analysis of the data collected with 4He and 16O beams is 
being finalized in order to produce a measurement of the absolute 
production fluxes: the observed raw yields are, however, encour-
aging for what concerns on-line monitoring applications.
3. THE EXPLOITATION OF CHARGED 
PARTICLE DETECTION FOR RANGE 
MONITORING
3.1. The Charged Particles Emission 
Distribution
The measurement of the emission shape distribution of the 
charged particles produced by the beam interactions with the 
FIGURE 9 | Principle of single proton interaction vertex imaging 
(SP-IVI) and double proton IVI (DP-IVI) as analyzed in Ref. (27). 
© Institute of Physics and Engineering in Medicine. Reproduced by 
permission of IOP Publishing. All rights reserved.
FIGURE 10 | From Ref. (30): schematic view of the beam spot size 
contribution to the uncertainty on the reconstruction of the fragments 
emission region in the case of an experimental setup placed at an 
angle θ with respect to the primary beam direction. © Institute of 
Physics and Engineering in Medicine. Reproduced by permission of IOP 
Publishing. All rights reserved.
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patient tissue was recently presented in Ref. (25, 27) in the 
context of discussing the possible strategies for the development 
of an on-line tool for PT treatments monitoring. Two possible 
approaches were investigated with the help of Monte Carlo 
simulations calibrated on the measurement reported in Ref. (21, 
22): single proton interaction vertex imaging (IVI) and double 
proton IVI, whose principle is sketched in Figure 9.
More sophisticated algorithms based on the determination 
of most likely trajectory [MLEM, for instance, Ref. (39)] could 
be also envisaged, but the simple imaging approach sketched in 
Figure 9 is already showing the monitoring approach fundamen-
tal principles.
Although Double Proton imaging would lead, in principle, to a 
safer determination of the primary path in the target by requiring 
the simultaneous emission and detection of a pair of protons, it 
reduces too much the statistic of the available signal sample.
A Single Proton imaging approach turns out then to be the 
only possible solution. However, in this case, the knowledge in 
real time of the beam position in the transverse plane during the 
monitoring procedure would be needed. As this information can 
be easily obtained from the beam delivery system, the emission 
point of the detected secondary particle can be obtained as the 
point of closest approach between the known beam line and the 
measured secondary particle direction.
The discussion about the optimal angle at which a monitoring 
detector exploiting the secondary charged radiation should be 
placed with respect to the primary beam direction (see Figure 9) 
was addressed, for the first time, in the framework of the IVI 
approach. Still, the choice of such geometrical parameter has a 
strong dependence on the angular distribution of the emitted 
charged secondary fragments and on the final accuracy that is 
achievable on the BP position. This turns out to be fundamental 
in any dose profile monitoring application.
At small detection angles, the emission flux increases and 
the charged particles energy spectrum is shifted toward higher 
kinetic energies. This configuration maximizes the charged 
fragments statistics that can escape the patient body, and be 
detected, while minimizing the Multiple Scattering (MS) inside 
the patient.
On the other hand, the accuracy on the charged emission 
point is maximal, for geometrical reasons, for orthogonal detec-
tion with respect to the beam line. As shown in Figure 10, if the 
projection (shadow) of the beam spot on the beam line is taken 
into account, the spatial resolution on the emission shape wors-
ens as (sin θ)−1. This effect is described by a term ≃ σbeam × cot(θ) 
that becomes dominant for small detection angles. The above 
considerations lead the authors of Ref. (30) to focus on the 
measurements at large angle with respect to the primary beam 
directions, as already discussed in Section 2. When designing an 
operational setup to be used in actual treatments, the accuracy 
gain that could be achieved, from a geometrical point of view, 
at large θ has to be taken into account in combination with the 
already mentioned larger statistic and the higher average kinetic 
energy of the emitted particle at smaller angles, in order to obtain 
the necessary optimum trade off.
FIGURE 11 | Simulation of SP-IVI reconstructed vertex distributions 
for a low beam energy 12C of 95 MeV/u in PMMA for different targets 
thickness, as calculated in Ref. (27). © Institute of Physics and 
Engineering in Medicine. Reproduced by permission of IOP Publishing. 
All rights reserved.
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A key point in the range monitoring with charged particles 
is the correlation of the charged secondary emission profile 
with  the beam dose release, and in particular with the BP 
position. A typical approach is to correlate the fall-off of the 
emission profile with the BP position, as shown in Figure 11 
from Ref. (27), where the fall-off of the simulated SP-IVI recon-
structed vertex distributions for a 95 MeV/u 12C beam is shown 
in case of different thicknesses of material (PMMA) crossed 
from the emission point to the detector. The smooth lines cor-
respond to fits of equation (1) where the complementary error 
function (erfc) is being used.
 f x a b erfc c x d( ) [ ( )]= + × −  (1)
The d parameter, which corresponds to the inflection point 
position, is assumed to provide information that can be correlated 
to the primary ion range.
The authors of Ref. (27) pointed out that the target thickness 
slightly affects the vertex distribution shape, since the secondary 
protons absorption affects the low-energy protons produced 
upstream less than those emitted at the end of the ion path. They 
also concluded that, probably, the proposed fit function is not 
appropriate in high attenuation conditions.
In Ref. (30), a different function is proposed to fit the longitu-
dinal emission distribution of charged particles detected at large 
angles (equation (2)).
 f x p exp exp
px p
p
x p
p
( ) =
+ ( ) + −( ) + .− −0 5
1
1
1
11
2
3
4
 (2)
Figure  12 (left) shows the measured longitudinal emission 
distribution of charged particles emitted at 90° (solid line) by a 
220 MeV/u 12C beam in a PMMA phantom, with a superimposed 
depth-dose profile as calculated with the FLUKA Monte Carlo 
code (36, 37) (hatched-area distribution). A clear correlation is 
observed between the beam entrance position in the target and 
the rising edge of the xPMMA distribution.
The right panel of Figure 12 shows that the xPMMA distribution 
is well described by equation (2): parameters p3 and p1 are, respec-
tively, related to the rising and falling edge of the distribution, 
while the rising and falling slopes of the function are described 
by p4 and p2. A flat background contribution is accounted for 
through parameter p5. The beam finite size can be explicitly added 
at different detection angles with respect to the beam direction as 
a convolution term of a Gaussian function with σ ≃ σbeam × cot(θ). 
equation (2) accurately described all the measured emission pro-
files for different isotopes and data samples taken with different 
geometrical conditions (beam entrances) and angle configura-
tions (60° and 90°).
Using this functional form, two quantities have been derived 
that are directly related to the beam range: Δ40 and δ40, as shown 
in the right panel of Figure 12. Δ40 represents the width of the 
f(x) distribution at 40% of its maximum, Xleft and Xright being, 
respectively, the corresponding x-values at the rising and falling 
edges. δ40 represents the distance between Xleft and the x-intercept 
of the tangent to f(x) at x = Xright.
Several elements influenced the accuracy of the proposed 
methods in monitoring the Bragg peak position: the multiple 
scattering undergone by the fragments inside the body, the 
collected sample statistics, and the intrinsic fluctuation of the 
emission process related to the nuclear interactions. This last 
contribution has been studied using a fixed number (103) of 
detected fragments. Samples of 103 tracked charged fragments 
were created out of the datasets acquired at each angular con-
figuration, for a total of 13 samples at 90° and 100 samples at 60°. 
When comparing the measurements of Δ40 and δ40 performed at 
different angles, the finite spot size of the beam σbeam (Figure 10) 
was taken into account.
The accuracy on the measurement of the Δ40, δ40, and Xleft 
together with the average values of Δ40 and δ40 are shown in 
Table  1. The accuracy achieved for the statistic of the refer-
ence sample (1k tracks) is of the order of 3 mm. The measured 
absolute values of Δ40 and δ40 should be compared with the path 
Δbeam = 8.90 ± 0.03 cm, traveled by the primary beam from its 
entrance position in the target to the Bragg peak position, which 
was determined from the MC simulation used for the beam setup 
and calibration.
The reference sample (103 particles) used in Ref. (30) to 
validate the performances of the monitoring technique proposed, 
due to the reduced detector solid angle ΔΩ ≃ 10−4 sr, was pro-
duced by a number of carbon ions equal to ≃ 2.3 × 108 at 90° and 
to ≃ 4.7 × 107 at 60°. Those numbers can be reduced significantly 
(by even a factor 100) by increasing the solid angle of the tracker 
detector that, for clinical applications, can have a larger active 
area and be positioned closer to the patient.
To make a comparison with a standard carbon treatment, 
the number of carbon ions that are needed to give a 1 Gy dose 
to the distal part of the tumor (whose monitor accuracy is par-
ticularly important) has been computed: assuming that a slice of 
1 cm × 1 cm with 2-mm thickness is irradiated, about 107 carbon 
ions will be needed, distributed in a number of single spot pencil 
TABLE 1 | Dispersion and mean values of the parameters used to 
describe the charged fragments emission distribution for each angle 
configuration tested in Ref. (30).
Angle 
(deg)
σΔ (cm) σδ (cm) σXleft (cm) D40 (cm)  δ 40 (cm)  
90 0.34 0.37 0.08 6.60 9.40
60 0.31 0.28 0.09 6.83 9.44
The parameters are correlated to the beam entrance position in the PMMA and to 
the BP as described in Ref. (30). The resolutions are evaluated as the RMS of the 
measurements performed in the different beam entrance configurations and data 
samples.
FIGURE 12 | From Ref. (30): left, longitudinal profile (solid line) of secondary charged particles as a function of the penetration in a PMMA phantom 
at 90° detection angle (beam entrance −6.15 cm). Superimposed (hatched), it is shown the beam depth-dose distribution as from MC simulations. Right, 
longitudinal profile (solid line) as above but with the PDF from equation (2) superimposed. The dotted and solid arrows show the graphical representation of Δ40 
and δ40, respectively. The variables Xleft and Xright are also shown. © Institute of Physics and Engineering in Medicine. Reproduced by permission of IOP Publishing. 
All rights reserved.
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beam each one made of about 2 × 105 primaries. The numbers 
of produced charged fragments that will be detected by a given 
ΔΩ detector at 90° and 60°can be easily deduced from the results 
quoted above.
Beside the number of primary ions that are used, another 
important parameter that has to be considered when discussing 
real case scenarios is the amount of patient tissue crossed by the 
secondary particles in their exit path, before their detection. As 
the absorption increases with the traversed matter, a reduction of 
the flux up to a factor 10 has to be considered in case of tumors 
that are located very deeply in the patient body, as can be inferred 
from Figure 11.
The accuracy achievable is, therefore, function of the signal 
tracks statistics, and hence on the dose administered in a given 
fraction, and of the absorption due to the depth of the tumor. 
In order to enhance the signal statistics, a possible strategy is to 
envisage the monitor of a group of pencil beams in the same treat-
ment slice. At the same time, the maximization of the geometrical 
acceptance of the monitor device is also crucial, getting as close 
as possible to the patient, to enhance the collected tracks sample 
statistics and, hence, the accuracy attainable with a small number 
of pencil beams.
3.2. An Application to the Clinical 
Environment: The Dose Profiler
As discussed in the previous section, in order to exploit the 
detection of charged particles for range monitoring in PT a 
large acceptance is needed. Other requirements to be taken into 
account in the detector design are compactness, reliability, and 
high tracking efficiency. We will consider, as practical example 
to discuss the application to a clinical environment, the Dose 
Profiler (DP) device (40) developed in the framework of the 
INSIDE (INnovative Solutions for In-beam Dosimetry in hadron-
thErapy) project (41). The tracker implemented within INSIDE 
is built out of six double planes of scintillating fibers oriented in 
two orthogonal views to provide bi-dimensional readout, with a 
sensitive area of about 20 cm × 20 cm. The fiber transverse section 
(500 μm × 500 μm) provides the necessary spatial resolution for 
an accurate reconstruction of the charged tracks, considering 
that the resolution on the fragment emission point is dominated 
by the Coulomb and nuclear scattering undergone in the patient 
tissues in the exit path.
Some of the practical features related to the application of a 
charged particle-based monitoring technique to PT treatments 
were addressed using Monte Carlo simulations. A real case sce-
nario was studied in detail by performing an accurate FLUKA 
MC simulation of the treatment with 12C ions undergone by 
a patient at the Italian hadrontherapy center CNAO (42). The 
treatment was a two-port irradiation of a chordoma (volume of 
about 45 cm3) placed almost at the center of the head.
FIGURE 14 | Number of prompt photons (blue) and protons (red) per carbon ion in the acceptance of the INSIDE Dose Profiler detector as obtained 
by the simulated treatment planning at an angle of ~60° with respect to the primary beam, for a single fraction of the treatment of Figure 13.
FIGURE 13 | Simulated treatment plan of a chordoma as displayed by the Treatment Planning System (Syngo TPS by Siemens) for a patient treated 
with 12C ions at the Italian hadrontherapy center CNAO (42): transaxial (left), sagittal (center), coronal (right) views. Courtesy of CNAO.
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The simulation reproduced all the details of the beam delivery 
and the actual geometry of the patient, importing the CT image 
(see Figure 13). The output from the Treatment Planning System 
(Syngo by Siemens) was coupled to the simulation input and a 
single fraction of the treatment was considered for one of the 
two beam ports. The energy of the 12C primary ions for such a 
treatment was in the range of 137.28–243.42 MeV/u. The total 
number of primaries used for the simulation of a given treatment 
fraction was 2.7 × 108.
Prompt photons and secondary protons emerging from the 
patient with an energy greater than 1 and 20 MeV, respectively, 
were studied. The INSIDE tracking detector was placed at a 
distance of 40 cm from the tumor at about 60° with respect to 
the beam direction. The total number of photons and protons 
entering in the detector acceptance are 2.7 × 106 and 6.4 × 105, 
respectively.
In Figure 14, the expected numbers of photons and protons 
for each carbon ion entering the detector active area, placed at 60° 
with respect to the primary beam incoming direction, are shown 
as a function of the beam energy. The Monte Carlo evaluation 
of the proton flux at 220 MeV/u is compatible with the results 
reported in Section 2.
The application of these techniques to the “online” (in-treat-
ment) monitoring of the beam range requires a calibration of the 
FIGURE 15 | Simulation of the reconstructed longitudinal profile of the 
emission points of secondary protons as detected at 90° with respect 
to the beam direction, for 12C beam of 220 MeV/u irradiating a 
cylindrical PMMA target, for different targets radii.
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measured parameters used to describe the longitudinal emission 
distribution (the Δ40, δ40 parameters introduced in the previous 
paragraph). The dependence of Δ40 and δ40 against the actual BP 
position for the energy of interest or, correspondingly for the 
carbon beam range of interest in PT, has to be performed by 
means of an extended campaign of experimental measurements.
In order to implement the monitoring technique here pro-
posed in actual clinical cases, a possible strategy is described in 
the following. Any complex geometry, like the case of a patient, 
having different materials, densities, and thicknesses will produce 
a longitudinal emission profile that will be quite different from 
the reference case presented so far. However, since all the relevant 
information is in principle contained in the patient’s CT, it is pos-
sible to develop a method that allows to take into account all the 
deformations of the secondary charged emission shape due to the 
absorption of charged fragments in the patient tissue, as indicated 
in Figure 11.
The reference emission shape, whose correlation with the BP 
position is known, can be obtained from the measured emission 
shape by unfolding the expected absorption as a function of 
thickness (obtainable from the CT) along the reconstructed track 
direction. A function describing particle absorption in different 
materials can be reliably obtained by Monte Carlo simulation. 
In order to give a proof of principle of the proposed method, we 
have developed a Monte Carlo simulation calibrated with the 
data reported in Section 2. Using the same beam and detector 
conditions employed in the real case scenario simulation shown 
in Figure 13 (primary 12C beam of 220 MeV/u, DP detector), the 
attenuation of protons emitted at 90° with respect to the beam 
incoming direction has been obtained for PMMA as a function 
of the thickness of material crossed by the fragments. Results are 
shown in Figure 15.
In real case scenarios, look-up tables will be used for different 
beam energies and “water equivalent material” thicknesses. The 
emission shapes predicted for different thicknesses of Figure 15 
have been fitted using the function of equation  (2). In order 
to parameterize the functional shape for an arbitrary value x 
of thickness, the variation of the six pi parameters that enter 
the function definition has been studied as a function of x by 
means of simple polynomial fits, as shown in Figure 16, in the 
2.5–10 cm range.
Once the “look-up tables” are available, to take into account 
the variation of the pi parameters as a function of the material 
thickness, the emission function of equation (2) can be general-
ized as a two variables function of z, the emission point along 
the beam path, and of the crossed material thickness x traversed 
in the escape path from the phantom, using the pi(x) functions:
 f z x p x exp exp
p xz p x
p x
z p x
p x
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A weighting function can be defined for each charged second-
ary track with emission point reconstructed at position z and with 
crossed material x before escaping the patient:
 w z x f z x
f z x
( ) ( )
( )
, =
,
,
0  (4)
Here, the reference x0 correspond to the minimum 2.5  cm 
thickness of the PMMA used to collect the data (30) on which 
the simulation has been trained. In order to take into account the 
absorption effect, any detected track will contribute to the emis-
sion shape with a weight w(z, x) evaluated using the measured z 
and the x obtained from CT.
In order to demonstrate the feasibility of the proposed 
approach, we have simulated a simple system, shown in Figure 17, 
where a 12C beam propagates in a PMMA sphere of 10-cm radius 
(density ρ = 1.2 g/cm3), that contains a smaller sphere of density 
ρo =  0.6  g/cm3 and radius =  3  cm. The detector used for the 
MC simulations is the INSIDE Dose Profiler, placed at a 40 cm 
distance from the center of the larger sphere. In this case, the 
thickness x of crossed material can be calculated analytically.
Figure 18 shows the result of the unfolding procedure. The 
left panel shows the MC profile of the emitted charged secondary 
particles as produced by the beam, while the emission profile 
reconstructed by the detector is shown in the central panel. The 
distortion in the reconstructed shape due to the different material 
thickness is evident as well as the heavy implications for the cor-
rect evaluation of the BP position when using the biased recon-
structed distribution without any correction. By weighting each 
reconstructed track with the inverse of the weight w(z, x) defined 
in equation (4), the result shown in the right panel is produced, 
where the re-weighted profile is superimposed to the generated 
one. The nice agreement obtained proves the feasibility of a meas-
urement of the true charged secondaries emission profile, once 
the detailed map of the material crossed by the detected protons 
is known. In a real case scenario, a software system capable of 
exploiting on-line all the useful information from the CT has to 
be implemented.
The proposed technique, beside the monitoring of the BP posi-
tion, could also be used to provide additional information about 
the patient positioning. By the correlation of the beam entrance 
position in the patient to Xleft (for the definition and the expected 
FIGURE 17 | Simulation setup for a proof of concept of the material 
absorption deconvolution.
FIGURE 16 | Polynomial fit modeling the evolution of the parameters of equation (2) resulting for different thicknesses of material crossed by the 
charged secondary particle as shown in Figure 15.
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resolution refer to Table  1 and Figure  12) a fast and precise 
feedback on possible patient mis-positioning could be provided 
during the treatment.
4. CONCLUDING REMARKS
Nowadays, the baseline approach for PT range monitoring 
is through PET imaging, typically undergone by the patient 
immediately after the treatment. In order to improve the treat-
ment reliability and ensure an accurate control on the dose depo-
sition, different research groups are developing and optimizing 
a dedicated monitoring device capable of being operated during 
the treatment.
Techniques based on the detection of secondary prompt 
photons are recently starting clinical experimentation: first 
prototypes are being developed and tested “in room” with an 
optimization focused mainly on applications to proton therapy 
(43). At the same time, a monitoring technique based on the 
detection of charged particles is being developed. The prelimi-
nary studies and experimental results presented in this review 
showed that promising performances are expected for such 
technique when applied to the monitoring of ion treatments, as 
proton projectiles would produce an insufficient yield of charged 
secondaries.
An advantageous strategy that can be pursued to achieve the 
desired monitoring space resolution implies the detection of frag-
ments emitted at large angles with respect to the beam incoming 
direction, even at the price of having a lower yield of particles as 
they are emitted preferentially in the forward direction. In this 
case, the reduction of the MS undergone inside the patient body 
and the reduction of the beam shadow effect will help significantly 
in matching the monitoring requirements posed by the clinical 
application.
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FIGURE 18 | True (left panel) and detected (middle panel) secondary charged particles emission profiles obtained from the MC simulation setup 
of Figure 17. The right panel shows the effect of the re-weighting procedure described in the text, needed to account for the different material traversed by the 
secondary fragments.
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The application of a charged particle-based monitoring could 
be problematic in case of deep seated tumors, because of the 
re-absorption of charged secondaries inside the patient itself. 
However the technique feasibility is fully recovered in the context 
of hypo-fractionated treatments. For those treatments, the need 
for on-line range check is even more compelling as very large 
doses are delivered in one or few shots, and the total dose for 
the single irradiation session, and the related secondary yields, 
can be almost one order of magnitude larger than the standard 
treatments.
The three leading techniques that are nowadays being con-
sidered for in-beam range monitoring (PET, prompt gammas 
and charged particles) offer in principle different advantages 
and pose different problems. The performance comparison of 
the three approaches is not trivial. One reason is that many 
of the proposed detectors and approaches still do not have 
firmly established performances, since they are in a research 
and development phase. Another reason resides in the limited 
reliability of the nuclear interactions description in Monte 
Carlo codes in the energy range of few hundreds MeV/u. In this 
respect, the process of secondary charged particles emission at 
large angles is one of the most difficult to benchmark for the 
existing models.
The increasing amount of data coming from dedicated 
experimental campaigns, and the impressive modeling activity 
performed by the code developers, is allowing the MC simulation 
research field to evolve quickly. An example of recently achieved 
results is in Ref. (44) and in Ref. (13) specifically for the PET 
technique.
Finally, the relative performances of the three techniques 
strongly depend on the tumor size and position and on the 
absolute dose release foreseen for a given treatment. Combined 
approaches in which two or more secondary signals are simulta-
neously exploited are, thus, promising.
A first example of such integrated approach is being developed 
within the INSIDE (41) project: here, two planar PET heads made 
of pixellated LYSO crystals are operated in combination with 
the Dose Profiler, a large area charged particles tracker made of 
orthogonal layers of scintillating fibers. The PET subsystem has 
ToF and DAQ capabilities that allow for in-beam operation, while 
the tracker is focused on the detection of charged secondaries 
emitted at large angle (60°–90°) with respect to the beam direc-
tion. The test of the integrated device is foreseen in 2016, in the 
CNAO therapy center.
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